US Patent Issued to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY on May 27 for "Application of monocyclic Beta-lactam compound in pharmacy" (Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,948, issued on May 27, was assigned to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY Co. LTD (Shenzhen, China).

"Application of monocyclic Beta-lactam compound in pharmacy" was invented by Xiawei Wei (Chengdu, China), Charles Z. Ding (Shanghai), Jian Li (Shanghai), Shuhui Chen (Shanghai) and Yuquan Wei (Chengdu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An application of a compound represented by formula (I) and pharmaceutically acceptable salts thereof in preparation of a drug for treating pneumonia."

The patent was filed on Dec. 18, 2019, under Application No. 17/414,491.

*For further information, including images, charts and tables, please ...